Health TrialsbyHealthPanel

Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy

ConditionsAmblyopiaStrabismus
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-90
SponsorThe Cleveland Clinic

About this trial

Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binocular visual function deficits. Treated patients have residual visual function deficits. The purpose of the current study is to quantify various visual functions in amblyopic and strabismic participants at baseline, during and at the completion of treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

History of amblyopia or presence of amblyogenic risk factors.

Disqualifiers

History of neurologic disorders

Trial population

children with diagnosis of strabismus and/or amblyopia

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Patching therapy, Glasses

    Behavioral

    Patching, glasses and strabismus surgery are commonly employed measures in treatment of amblyopia and strabismus.

Treatment groups

150 Participants
are divided into 2 treatment groups
Group A: Control subjects0 interventions
Group B: Amblyopia1 intervention

Trial outcomes

Primary outcomes

1

Visual Functions

contrast sensitivity

Time frame
0-3 years depending on duration of treatment
2

Visual Functions

visual acuity

Time frame
0-3 years depending on duration of treatment
3

Visual functions

vernier acuity

Time frame
0-3 years depending on duration of treatment
4

Visual functions

grating acuity

Time frame
0-3 years depending on duration of treatment

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The Cleveland Clinic

Lead sponsor

Source ClinicalTrials.gov
Apply now